Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China

被引:32
作者
Hsing, Ann W.
Gao, Yu-Tang
McGlynn, Katherine A.
Niwa, Shelley
Zhang, Mingdong
Han, Tian-Quan
Wang, Bing-Sheng
Chen, Jinbo
Sakoda, Lori C.
Shen, Ming-Chang
Zhang, Bai-He
Deng, Jie
Rashid, Asif
机构
[1] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Shanghai Canc Inst, Shanghai, Peoples R China
[3] Hlth Studies Sector, Rockville, MD USA
[4] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Hong Kong, Peoples R China
[5] Raijin Hosp, Dept Surg, Shanghai, Peoples R China
[6] Shanghai Med Univ, Zhongshan Hosp, Dept Surg, Shanghai 200032, Peoples R China
[7] Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA USA
[8] Shanghai Tumor Hosp, Dept Pathol, Shanghai, Peoples R China
[9] Second Mil Hosp, Dept Surg, Shanghai, Peoples R China
[10] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
biliary tract cancer; family history; viral hepatitis; liver cirrhosis; family history of liver cancer; China;
D O I
10.1002/ijc.22375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biliary tract cancers are relatively rare but fatal tumors. Apart from a close link with gallstones and cholangitis, risk factors for biliary tract cancer are obscure. Chronic liver conditions, including liver cirrhosis, have been linked to a higher risk of biliary tract cancer. In a population-based case-control study conducted in Shanghai, China, we investigated the relationships of a history of chronic hepatitis and liver cirrhosis as well as a family history of liver cancer with biliary tract cancer risk. The study included 627 patients with biliary tract cancers (368 gallbladder, 191 bile duct and 68 ampulla of Vater), 1,037 patients with biliary stones (774 gallbladder stones and 263 bile duct stones) and 959 healthy subjects randomly selected from the population. Bile duct cancer was associated with self-reports of chronic liver conditions, including a history of chronic hepatitis (OR = 2.0, 95% CI 0.9-4.4), liver cirrhosis (OR = 4.7, 95% CI 1.9-11.7) and a family history of primary liver cancer (OR = 2.0, 95% CI 1.0-3.9). The excess risk persisted after adjustment for gallstones and were more pronounced among subjects without gallstones (OR = 5.0, 95% CI 1.3-20.0 and OR = 4.9, 95% 2.0-12.2, respectively). History of liver conditions was also associated with an excess of biliary stones (OR = 1.9, 95% CI 1.2-3.0). No association was found for cancers of the gallbladder and ampulla of Vater. A history of chronic hepatitis and cirrhosis may be risk factors for extraheptic bile duct cancer. Given that chronic infection with hepatitis B virus (HBV) is the most common cause of liver disease in China, serologic markers of HBV need to be measured in future studies to examine the link between HBV and bile duct cancer. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1981 / 1985
页数:5
相关论文
共 57 条
[1]   Gallbladder contractility in liver cirrhosis: Comparative study in patients with and without gallbladder stones [J].
Acalovschi, M ;
Dumitrascu, DL ;
Nicoara, CD .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (01) :17-24
[2]   Risk factors for symptomatic gallstones in patients with liver cirrhosis: A case-control study [J].
Acalovschi, M ;
Blendea, D ;
Feier, C ;
Letia, AI ;
Ratiu, N ;
Dumitrascu, DL ;
Veres, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (08) :1856-1860
[3]  
Acalovschi Monica, 2004, Rom J Intern Med, V42, P41
[4]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[5]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[6]  
Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
[7]  
Buchner AM, 2002, AM J GASTROENTEROL, V97, P905, DOI 10.1111/j.1572-0241.2002.05607.x
[8]   Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis [J].
Burak, K ;
Angulo, P ;
Pasha, TM ;
Egan, K ;
Petz, J ;
Lindor, KD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (03) :523-526
[9]   Risk factors for biliary tract carcinogenesis [J].
Chapman, RW .
ANNALS OF ONCOLOGY, 1999, 10 :308-311
[10]  
Chen R, 2000, CHIN J EXP SURG, V17, P223